Allogeneic regenerative medicine business

We will supply regenerative medical products with stable quality, and patients will be able to access high quality and continuous treatment at wide variety of medical institutions.
We keep on engaging in the business development to provide regenerative medicine to any people suffering from disease without complete cure. We call our MSCs as "gMSC®," represents “guaranteed” MSC, which is produced from allogeneic tissue using TWOCELLS’ originally developed serum-free media (STK® series) and culture technologies.

In comparison with the transplantation of autologous and allogeneic products in regenerative medicine, allogeneic transplantation is considered to be more suitable.
Our currently developing pipelines for allogeneic regenerative medical products are described here.